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F10-9,A7-12,E1-9 这三株 pGL3-SFiRE-NIH3T3 稳定细胞株。通过这个筛选模型
的筛选，最终得到了 191、LX、hZL02a-1、HQGa-9、Ty02b-5 这 5 种具有抑制活
性的粗提物。利用 western-blot 检测这些具有活性的粗提物对 FGF 信号传导通
路中关键酶的影响以及对 FGFR 的抑制情况。最终发现 Ty02b-5 和 180 这两种粗
提物抑制了 FGFR 的磷酸化，并且在对 p-PLCγ的检测中发现经过这两种粗提物
处理后 p-PLCγ的量明显减少。说明两种粗提物中的某种成分可能是我们所寻找





关键词：角质细胞生长因子 生物学活性 成纤维细胞生长因子受体 稳定转染 筛
选  抑制剂  

























The thesis consisit of two chapters,the first part is about study of the expression 
and bioactivity of KGF,the second part maily about the construction of FGFR screen 
model based on report gene. 
Keratinocyte growth factor (KGF) was purified from embryonic fibroblast 
culture fluid(Rubin et al.1989) which act specific on epithelial cells.Releasing by 
various mesenchymal cells, KGF can stimulate the proliferation, differentiation and 
migration of epithelial cells.A serious studies have provided insight into the function 
of KGF in repair processes of various tissues and organs, including skin, cornea, 
bowel. In addition, it is a protective factor for gastrointestinal injury induced by 
radiation and chemotherapy. Based on previous work, this paper focus on the 
expression, purification ,bioactive test of KGF and the research of scald agents. 
By changing the inducing temperature, inducer IPTG concentration, the density 
of bacteria and inducing time, the satisfying condition for expression of soluble fusion 
protein GST-KGF could be obtained at 22℃ ,0.5mmol/L IPTG, OD600 equals to 0.96, 
5h inducing time. Under the improved condition, the soluble GST-KGF comprised 
about 8.66% of total cellular protein and 28.39mg GST-KGF could be harvested in 1L 
fermentation. In the 50L fermentation system ,the soluble production up to 277.8mg/L 
which comprised about 29%of total cellular protein. 
A method which combined affinity chromatography and thrombin incubation 
was used to achieve KGF purification since the fusion protein GST-KGF could bind 
to GSH-Sepharose 4B and GST could be remove by thrombin.The 17KD KGF 
derived from GST-KGF was purified to homogeneity.83.0mg purified KGF, a total 
recovery of 29.9% KGF, was harvested.ELISA analysis showed that the purified KGF 
could be detected by rabbit against human KGF. 
Based on the previous work,the research on bioactivity of KGF was carried by 
the deep Ⅱ scald on the back of mice.Results show that the satisfying concentration 
of KGF used on the wound was 10μg.For the further study ,three different scald 















great promoted the wound healing which the healing rate is 30%-50% higher compare 
to the positive drugs.All the results prove that more the scald cream worth to be 
further developed. 
The basic fibroblast growth factors (bFGF) which was one member of fibroblast 
growth factors, was first isolated as mitogens from bovine brain tissue in the 
1970s.Fibroblast growth factors and their signaling receptors have been associated 
with multiple biological activities, including proliferation,differentiation and motility. 
Consequently, they have evoked interest as candidate oncogenes with the potential to 
initiate and/or promote tumorigenesis.This paper focus on the construct of stability 
screen model of FGFR（fibroblast growth factors receptor，FGFR）, the screen of 
extracts and exploring the the potential mechanism which these extracts act on the 
FGF signal pathway. 
We construct the stability screen model by the stable co-transfenction of two 
plasmids into the NIH3T3 cells and finally we get three stable pGL3-SFiRE-NIH3T3 
cell line which are F10-9,A7-12,E1-9.Furthermore,by screen the extracts we found the 
extracts NO.191,LX,hZL02a-1,HQGa-9,Ty02b-5 which have the potential inhibition 
activity.In addition,the mechanism research show that NO. Ty02b-5 and 180 could 
Inhibit the phosphorylation of FGFR,and their potential signal pathway were the 
PLCγ pathway. 
However more research need to discover the exact component which have the 
inhibition ability and the mechanism of they act on the FGFR. 
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1.1 KGF 概况 






的同源区域包括近羧基端约2/3 KGF 编码片段，在该区域，KGF 片段30% ～ 
50% 同源于FGF 家族的其他18 种蛋白[3]。 
KGF 基因位于15 号染色体（15q15-q21.1），包括3 个外显子和2 个内含子，


















。KGF 的cDNA 编码194 个氨基酸，包含
一分泌所需的信号肽和N 端的糖基化位点。重组人KGF（recombinant 





。KGF 的N 末端是由12 条反向
平行的链构成的三叶草型模序，KGF 的受体结合特异性、有丝分裂原特性及其
受体介导的磷酸化功能均存在于其中（Fig.1）。肽链前23 个氨基酸的缺失并不





并且缺乏组织选择性。在50℃孵育10 min 活性不受影响，60℃孵育10 min 活性







          








                           图 1 KGF 分子模型[8] 
   Fig.1  The  KGF  Molecule model 





















细胞、单核细胞、巨噬细胞、黑色素细胞不表达 KGF[ 9, 10 ] 。KGF 通路受到多
种因素调控，具体的调控因素可以大致分为以下几类：①细胞因子：KGF 表达
的上调受细胞因子和调控元件的影响。炎症浸润部位巨噬细胞和多核白细胞产生
的炎性因子 IL-1、IL-6 等，刺激多种来源的成纤维细胞合成 KGF mRNA 及其
蛋白产物。角质化细胞通过释放 IL-1β 调整成纤维细胞 KGF 表达，IL-1β 是
有效的成纤维细胞 KGF 诱导物，通过 c-Jun 途径发挥作用[11]。PDGF-BB 和
TGF-α 亦可诱导 KGF 表达。②激素：包括雄激素、雌激素和糖皮质激素，是
KGF 表达的重要调控因素。雄激素和雌激素能促进 KGF 表达，而糖皮质激素
显著降低 KGF mRNA 表达。③其他：KGF 与 FGFR-2- Ⅲ b 的结合必须有
HSPG 存在；KGF 与Ⅰ、Ⅲ型胶原的结合特性在某种程度上决定了其空间分布
的特异性；酪氨酸 769 是一个关键 KGFR 信号转导调整器，调整 KGFR 结合，
参与与有丝分裂原活化蛋白激酶（mitogen-activated protein kinase，MAPK）的完
全激活作用有关的磷脂酶 C γ 酪氨酸磷酸化，通过调整 FGF 受体作用底物 2 酪
氨酸磷酸化引起细胞增殖[12]；阿糖腺苷刺激提高 KGF 的基因表达水平及细胞外
蛋白水平[13]；超声治疗显示成纤维细胞早期 KGF 表达增加[14]。 
1.3 KGF 受体研究 
FGF做为 大的生长因子家族之一，是通过与其受体结合发挥其生物学作
用。由4种基因编码出7种FGF受体，它们分别是FGFR 1b , FGFR 1c,  FGFR 2b , FGFR 
































                 
                   图 2 FGF 受体图[14] 
Fig.2  Schematic diagram of  FGFR. 
 




1.4.1 KGF 与器官发育 
KGF 与多种组织和器官的发育有关。在各器官的组织发育过程中，KGF参与
了其分化调控作用。FGFR-2- Ⅲ b 产生于胚胎形成期，开始呈弥散分布，逐渐
聚集于由外胚层发育而来的器官上皮细胞上。而KGF 一般分布于邻近的间充质























DPCs 中KGF 水平刺激毛发生长[13]。 
卵泡：KGF在卵泡的发育过程中起了重要作用。用酶联免疫吸附法测定卵泡
中的KGF时,发现其在卵泡液中的浓度(2 194 ±87pg/mL )远远高于其在血浆中的




用卵泡刺激素( follicle stimulating hormone, FSH)处理后可增加16% ,用KGF
和FSH同时处理增加26% ,同时测量这3种情况下的抑制素-α的含量, 抑制素-α










FGFR-2- Ⅲ b 缺失将导致肾发育成具有较少集合管和肾单位的小肾[23]。 
肺：Mondrinos, M. J等应用包括生长因子、I型胶原、无血清培养基的3-D
培养基建立了胚胎肺组织模型，证明了KGF 是早期肺发育和肺泡Ⅱ型上皮细胞
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